Get the Stockscreener App
1.57
0.00%
0.00
China Sxt Pharmaceuticals Inc stock is traded at $1.57, with a volume of 17,398.
It is up +0.00% in the last 24 hours and down -10.80% over the past month.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
See More
Previous Close:
$1.57
Open:
$1.53
24h Volume:
17,398
Relative Volume:
0.04
Market Cap:
$182.16M
Revenue:
$1.93M
Net Income/Loss:
$-3.10M
P/E Ratio:
-0.0959
EPS:
-16.3657
Net Cash Flow:
$-1.93M
1W Performance:
-1.88%
1M Performance:
-10.80%
6M Performance:
-42.63%
1Y Performance:
-78.19%
1-Day Range:
$1.53
$1.57
1-Week Range:
$1.50
$1.645
52-Week Range:
$0.95
$7.84
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
1.57 | 184.48M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
China Sxt Pharmaceuticals Inc Stock (SXTC) Latest News
Regression analysis insights on China SXT Pharmaceuticals Inc. performanceQuarterly Market Review & Accurate Buy Signal Notifications - Newser
Chart based exit strategy for China SXT Pharmaceuticals Inc.2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
Published on: 2025-08-20 20:28:25 - Newser
Live market analysis of China SXT Pharmaceuticals Inc.Market Activity Report & Advanced Swing Trade Entry Plans - Newser
Published on: 2025-08-20 06:22:34 - Newser
Ranking China SXT Pharmaceuticals Inc. among high performing stocks via toolsJuly 2025 Decliners & Real-Time Market Sentiment Alerts - Newser
Has China SXT Pharmaceuticals Inc. formed a bullish divergenceMarket Growth Report & Reliable Price Action Trade Plans - Newser
How to build a dashboard for China SXT Pharmaceuticals Inc. stockJuly 2025 Outlook & Stock Portfolio Risk Management - Newser
Order flow analysis tools used on China SXT Pharmaceuticals Inc.July 2025 Drop Watch & AI Powered Market Entry Strategies - Newser
Technical signs of recovery in China SXT Pharmaceuticals Inc.July 2025 Patterns & Daily Profit Maximizing Tips - Newser
What institutional flow reveals about China SXT Pharmaceuticals Inc.July 2025 Action & Smart Allocation Stock Tips - Newser
Is China SXT Pharmaceuticals Inc. trending in predictive chart modelsWeekly Trade Recap & Daily Chart Pattern Signals - Newser
Applying Wyckoff theory to China SXT Pharmaceuticals Inc. stockJuly 2025 Summary & Accurate Technical Buy Alerts - Newser
Statistical indicators supporting China SXT Pharmaceuticals Inc.’s strengthMarket Performance Report & Real-Time Buy Zone Alerts - Newser
Market reaction to China SXT Pharmaceuticals Inc.’s recent newsWeekly Earnings Recap & Daily Oversold Bounce Ideas - Newser
Published on: 2025-08-19 14:22:59 - Newser
Does China SXT Pharmaceuticals Inc. qualify in momentum factor screeningMarket Movers & Free Real-Time Volume Trigger Notifications - Newser
What Fibonacci levels say about EFSCP reboundAnalyst Downgrade & Safe Entry Zone Identification - Newser
Published on: 2025-08-19 07:10:16 - Newser
Is China SXT Pharmaceuticals Inc. stock entering bullish territoryDividend Hike & Low Risk Growth Stock Ideas - Newser
Published on: 2025-08-19 04:27:58 - Newser
Strategies to average down on China SXT Pharmaceuticals Inc.2025 Risk Factors & Daily Profit Maximizing Tips - Newser
Using Bollinger Bands to evaluate China SXT Pharmaceuticals Inc.Oil Prices & High Return Trade Opportunity Guides - Newser
Will China SXT Pharmaceuticals Inc. bounce back from current supportWeekly Stock Summary & Capital Efficient Trading Techniques - Newser
China SXT Pharmaceuticals Inc. stock momentum explainedWeekly Gains Summary & Growth Oriented Trading Recommendations - Newser
Is it too late to sell China SXT Pharmaceuticals Inc.Treasury Yields & AI Powered Trade Plan Recommendations - Newser
How sentiment analysis helps forecast China SXT Pharmaceuticals Inc.2025 Major Catalysts & Community Verified Swing Trade Signals - Newser
China SXT Pharmaceuticals Inc. stock outlook for YEARQuarterly Market Summary & Stepwise Entry/Exit Trade Alerts - Newser
Quantitative breakdown of China SXT Pharmaceuticals Inc. recent moveWeekly Trade Report & Entry Point Confirmation Alerts - Newser
Why China SXT Pharmaceuticals Inc. stock attracts strong analyst attentionJuly 2025 Fed Impact & Community Shared Stock Ideas - Newser
Heatmap analysis for China SXT Pharmaceuticals Inc. and competitorsQuarterly Portfolio Summary & Free Real-Time Volume Trigger Notifications - Newser
Can you recover from losses in China SXT Pharmaceuticals Inc.Trade Performance Summary & Low Drawdown Investment Ideas - Newser
China Sxt Pharmaceuticals Inc Stock (SXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):